Roles of osteoprotegerin in endocrine and metabolic disorders through receptor activator of nuclear factor kappa-B ligand/receptor activator of nuclear factor kappa-B signaling

Roles of osteoprotegerin in endocrine and metabolic disorders through receptor activator of nuclear factor kappa-B ligand/receptor activator of nuclear factor kappa-B signaling

Endocrine and metabolic diseases show increasing incidence and high treatment costs worldwide. Due to the complexity of their etiology and mechanism, therapeutic strategies are still lacking. Osteoprotegerin (OPG), a member of the tumor necrosis factor receptor superfamily, appears to be a potential...

Full description

Bibliographic Details
Main Authors: Luodan Zhang, Fa Zeng, Minmin Jiang, Maozhen Han, Binbin Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
nuclear factor kappa-B ligand
receptor activator of NF-κB
osteoprotegerin
osteoporosis
cardiovascular disease
gestational diabetes mellitus
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2022.1005681/full

Internet

https://www.frontiersin.org/articles/10.3389/fcell.2022.1005681/full

Similar Items